Overview

Efficacy and Tolerability of Sucrosomial Iron vs Ferric Maltol in Iron Deficient Women

Status:
RECRUITING
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
This study aims to compare two oral iron treatments: Sucrosomial Iron and Ferric Maltolin women with mild to moderate iron deficiency anemia. Many patients experience gastrointestinal side effects or poor tolerance with traditional iron supplements, which can limit treatment adherence. Participants will be randomly assigned to receive either Sucrosomial Iron or Ferric Maltol for 12 weeks. The main goal is to determine whether Sucrosomial Iron is as effective as Ferric Maltol in normalizing hemoglobin levels.
Phase:
PHASE4
Details
Lead Sponsor:
Pharmanutra S.p.a.
Treatments:
ferric maltol